Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. The company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. In these areas, Jazz Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution and Erwinaze® (asparaginase Erwinia chrysanthemi) in the U.S., and markets Erwinase® and Defitelio® (defibrotide) in countries outside the U.S. For more information, please visit www.jazzpharmaceuticals.com.
Why Work Here
Supporting our patients starts with supporting our employees. Jazz Pharmaceuticals has been successful because of the collaborative and passionate nature of our team. Each and every member of our team is critical to helping patients and to our continued success as a company. Our mission — as individuals and as a company — is to improve patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. Employees at all levels share a mutual respect for each other based on their drive to help accomplish this mission. Our patient focused and collaborative culture has allowed us to experience strong corporate growth, which continues to build upon a dedicated development team, a focused commercial team and a seasoned management team, all working together to the betterment of patients. The work we do is driven by one simple motivator: a genuine desire to improve lives. This is a universal truth across the entire organization, no matter the location, therapeutic focus, discipline or level of the individual.
Check out careers at Jazz Pharmaceuticals here
Join us at the Fall 2018 Biotech Bay Talent Connect in South San Francisco, CA. Click here to register today!
Connect With Jazz Pharmaceuticals
There are currently no jobs.